NeuroVigil Company
%20.jpg)
NeuroVigil is a leading neurotechnology revolutionizing EEG analysis for clinical trials, communication and space applications.
Estimated Revenue:
$1M to $10M
Funding Status:
N/A
Industry:
Space Medicine
Number Of Exists:
N/A
Technology:
Neuropharmacology
Founded Date:
2007
Investor Type:
N/A
Headquarters:
United States
Employee Number:
1-10
Investment Stage:
N/A